Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 2019

View Archived Issues

Signature matching for PARP inhibitors

Melanocortin receptor signaling can cut both ways in obesity

Glycosylation controls proteasome activity via sequence editing

DDS-04a demonstrates potent antimicrobial activity against Enterobacteriaceae variants

Strengthening muscle cell production

Identification and targeting of an RNA-binding protein network in acute myeloid leukemia

Gene amplification leads to pathway addiction for NAD synthesis

Immunitor initiates phase II study of oral V-Boost vaccine to treat glioblastoma

VNRX-7145 has promising preclinical profile and is ready to enter phase I studies

IONIS-DGAT2RX shows safety and efficacy in phase II study

Cidara Therapeutics develops long-acting, bispecific antiviral Fc conjugate for influenza

Promising activity seen with DA-7310 in preclinical models of Gram-negative infection

FAK inhibitor APG-2449 enhances activity of antitumor agents

Development of novel hamster-L5 model to investigate pathophysiology of atherosclerosis

Chinese researchers patent BTK inhibitors

GlaxoSmithKline presents new RORC antagonists

Medshine Discovery and collaborator identify adenosine A2A receptor antagonists

GlaxoSmithKline discloses BRD4 inhibitors

Enrollment opens in phase I study of IMA-203 TCR-engineered T cells for solid tumors

Haplogen presents new PLA2 inhibitors

Scancell cleared to begin U.K. arm of SCIB-1 phase II trial in advanced melanoma

Forge Therapeutics, Basilea Pharmaceutica enter research collaboration to develop novel antibiotics

Selective and potent RAS inhibitor MCI-062 active against RAS-driven cancers

Emendo Biotherapeutics signs licensing agreement with Takeda Pharmaceutical for OMNI nuclear program

FDA accepts IND for AR-13503 sustained-release implant for wet AMD and DME

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...